Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease-Reference-Cited by-同舟云学术

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

Published:2016-10-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chande Nilesh¹,Townsend Cassandra M²,Parker Claire E³,MacDonald John K²

Affiliation:

1. London Health Sciences Centre - Victoria Hospital; Room E6-321A 800 Commissioners Road East London ON Canada N6A 5W9

2. University of Western Ontario; Department of Medicine; London ON Canada

3. Robarts Clinical Trials; 100 Dundas Street, Suite 200 London ON Canada N6A 5B6

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000545.pub5/epdf/full

Reference112 articles.

1. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomized, investigator-blind study;Ardizzone;Digestive and Liver Disease,2003

2. Controlled Trial Comparing Intravenous Methotrexate and Oral Azathioprine for Chronic Active Crohn's Disease: Preliminary Report;Ardizzone;Gastroenterology,1999

3. A controlled double blind study of azathioprine in the management of Crohn's disease;Candy;Gut,1995

4. Infliximab, azathioprine, or combination therapy for Crohn's disease;Colombel;New England Journal of Medicine,2010

5. Supplementary Appendix;Colombel;New England Journal of Medicine,2010

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases;mSystems;2024-08-20

2. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline;Zeitschrift für Gastroenterologie;2024-08

3. Perianal disease in inflammatory bowel disease: Broadening treatment and surveillance strategies for anal cancer;World Journal of Gastroenterology;2024-07-28

4. IBD Patients with Primary or Secondary Nonresponse to Ustekinumab Benefit from Dose Escalation or Reinduction;Journal of Clinical Medicine;2024-07-09

5. Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn’s disease patients;The Pharmacogenomics Journal;2024-06-21